Gilead sciences News: Gilead sciences Latest News, Gilead sciences Today news, Gilead sciences Breaking News

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at…

March 12, 2025 17:05 IST

Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and received…

October 3, 2024 12:49 IST

Altogether, 22 EU member states and countries are participating in the joint procurement, under which they can purchase up to…

July 20, 2022 18:59 IST

The rally that pharmaceutical companies have witnessed on Dalal Street in the past few months has seen a lot of…

Updated: May 13, 2020 11:32 IST

Under the terms of the settlement, Natco’s partner Alvogen will be able to market the oseltamivir phosphate capsules Natco Pharma…

December 14, 2015 16:33 IST

The unit is likely to come up in proposed ‘Pharma City’

December 7, 2015 12:28 IST

Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease

May 4, 2015 13:25 IST

Natco Pharma has signed a non-exclusive licensing agreement with US-based Gilead Sciences to manufacture and sell generic versions of its…

March 3, 2015 03:40 IST

To manufacture and distribute Tenofovir Alafenamide (TAF) based HIV treatments in 112 developing countries

January 20, 2015 15:18 IST

Gilead Sciences